Other safety alerts
|
| |
| The United States: Counterfeit Versions of Cialis tablets identified entering the United States |
| |
FDA is alerting consumers and health care professionals that counterfeit versions of Cialis 20 mg tablets (lot: AC 066018) were found in the mail on its way to a U.S. consumer. While this shipment was stopped, FDA is concerned about other possible mail shipments to consumers. FDA laboratory analysis showed the counterfeit versions contain multiple active ingredients, which if used could result in adverse effects or harm.
Consumers are advised that they should only buy prescription medicines from state-licensed pharmacies located in the U.S. FDA cannot confirm that the manufacturing, quality, storage, and handling of these products follow U.S. standards because these products are from an unknown source. Therefore, these products are considered unsafe and should not be used. FDA also recommends consumers talk to their health care professional about their condition and options for treatment if they received a counterfeit product.
Please refer to the following website in FDA for details:
http://www.fda.gov/Drugs/DrugSafety/ucm431071.htm
In Hong Kong, Cialis Tab 20mg (HK-51229) is a pharmaceutical product registered by Eli Lilly Asia, Inc. (Eli Lilly), and is a prescription-only medicine. As confirmed with Eli Lilly, the company does not have any records of the importation of the particular batch (Lot: AC 066018, Exp: 01 Sep 17) of Cialis 20mg into Hong Kong, and the concerned batch is not a genuine product of Eli Lilly.
Ends/ Thursday, January 22, 2015
Issued at HKT 16:00
|
| |
|
